Company intelligence / Profile preview

Adroit Science

Lund, Skåne, Sweden

Ownership: Private
Employees: ~15
Development stage: Other

Overview

Adroit Science is a specialist contract research organization (CRO) that provides advanced solid-state characterization and formulation development services for the pharmaceutical industry. Based in Sweden, the company focuses on optimizing the physical properties of drug substances, including crystallinity, polymorphism, and stability. Their services help bridge the gap between drug discovery and clinical development by ensuring robust formulation strategies. In 2020, Adroit Science was acquired by SE Tylose, a subsidiary of Shin-Etsu Chemical, to strengthen their global pharmaceutical excipient business.

Modalities: Small molecule
Industry: Contract Research Organization

Partnerships

Shin-Etsu ChemicalSE Tylose

Beyond the preview

Go deeper on Adroit Science.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adroit Science.

Explore the full profile